| Structure | Chemical Name | CAS | MF |
|
WF 11899A
|
160335-87-5
|
C51H82N8O21S
|
|
Neodecanoic acid, oxiranylmethyl ester, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol, hexahydromethyl-1,3-isobenzofurandione and 1,3-isobenzofurandione
|
160336-54-9
|
|
|
Oxireno[c][1,2,4]triazolo[4,3-a]pyridine(9CI)
|
160336-99-2
|
C6H3N3O
|
|
|
Corticatic acid C
|
160337-75-7
|
|
|
insulin glargine
|
160337-95-1
|
C267H404N72O78S6
|
|
1,2,3,4-TETRAHYDRO-ISOQUINOLINE-7-CARBOXYLIC ACID
|
160346-57-6
|
C10H11NO2
|
|
BOC-D-PYR-OH
|
160347-90-0
|
C10H15NO5
|
|
FMOC-N-OMEGA-NITRO-D-ARGININE
|
160347-94-4
|
C21H23N5O6
|
|
5-BROMO-2,4-DIHYDROXYBENZOIC ACID MONOHYDRATE
|
160348-98-1
|
C7H7BrO5
|
|
(R)-2-(CBZ-AMINO)-3-(TERT-BUTYL-DIMETHYLSILYLOXY)-N-METHOXY-N-METHYLPROPANAMIDE
|
160349-51-9
|
C19H32N2O5Si
|
|
POTASSIUM THIOCYANATE-15N
|
160350-71-0
|
CKNS
|
|
4-TRIBUTYLSTANNANYLPYRIDINE-3-CARBOXALDEHYDE
|
160351-06-4
|
C18H31NOSn
|
|
Cyclobutanecarboxylic acid, 3-hydroxy-, ethyl ester, trans- (9CI)
|
160351-88-2
|
C7H12O3
|
|
Cyclobutanecarboxylic acid, 3-hydroxy-, ethyl ester, cis- (9CI)
|
160351-97-3
|
C7H12O3
|
|
Carbamic acid, N-(2-formylphenyl)-, methyl ester
|
160354-69-8
|
C9H9NO3
|
|
3,9-Diazabicyclo[3.3.1]nonan-7-amine,3,9-dimethyl-(9CI)
|
160357-81-3
|
C9H19N3
|
|
4-(benzyloxy)cyclohexanaMine
|
160357-83-5
|
C13H19NO
|
|
N-(4-aminocyclohexyl)acetamide
|
160357-84-6
|
C8H16N2O
|
|
1-PYRIDIN-3-YLMETHYL-PIPERIDIN-4-YLAMINE
|
160357-88-0
|
C11H17N3
|
|
1-PYRIDIN-4-YLMETHYL-PIPERIDIN-4-YLAMINE
|
160357-89-1
|
C11H17N3
|
|
1-PYRIDIN-2-YLMETHYL-PIPERIDIN-4-YLAMINE
|
160357-91-5
|
C11H17N3
|
|
1-Acetylpiperidin-4-amine
|
160357-94-8
|
C7H14N2O
|
|
1-TERT-BUTYLPIPERIDIN-4-AMINE
|
160357-95-9
|
C9H20N2
|
|
2-(2-Fluoro-phenyl)-2-methyl-propylamine
|
160358-03-2
|
C10H14FN
|
|
1-(2-fluorobenzyl)piperidin-4-amine(SALTDATA: 1.98HCl 0.75H2O)
|
160358-06-5
|
C12H17FN2
|
|
N-desethylatevirdine
|
160360-41-8
|
C19H21N5O2
|
|
fomivirsen
|
160369-77-7
|
C204H243N63Na20O114P20S20
|
|
Samarium sm 153 lexidronam pentasodium
|
160369-78-8
|
C6H12N2Na5O12P4Sm
|
|
2-Propenenitrile, polymer with ethenylbenzene and methyloxirane polymer with oxirane ether with 1,2-propanediol (2:1), graft
|
160369-81-3
|
C19H29NO4
|
|
Carbamo(thioperoxoic) acid, dimethyl- (9CI)
|
160369-82-4
|
C3H7NO2S
|
|
N-(5-AMINO-1-CARBOXYPENTYL)IMINODIACETIC ACID
|
160369-83-5
|
C10H18N2O6
|
|
AC-LEU-VAL-PHE-ALDEHYDE
|
160369-84-6
|
C22H33N3O4
|
|
5-Bromo-4-chloro-3-indolyl-alpha-D-N-acetylneuraminic acid sodium salt
|
160369-85-7
|
C19H23BrClN2NaO9
|
|
C-REACTIVE PROTEIN (174-185)
|
160369-86-8
|
C62H93N13O16
|
|
1-(1-broMoethyl)-3,5-bis-trifluoroMethyl-benzene
|
160376-84-1
|
C10H7BrF6
|
|
5-(4-Bromophenyl)pyrimidine
|
160377-42-4
|
C10H7BrN2
|
|
5-(4-BROMOPHENYL)-2,4-DIHYDRO-2-METHYL-3H-PYRAZOL-3-ONE
|
160377-46-8
|
C10H9BrN2O
|
|
5-(4-IODOPHENYL)ISOXAZOLE
|
160377-48-0
|
C9H6INO
|
|
3-(3-BROMOPHENYL)-5-METHYL-1,2,4-OXADIAZOLE
|
160377-57-1
|
C9H7BrN2O
|
|
5-(3-BROMOPHENYL)-3-METHYL-1,2,4-OXADIAZOLE
|
160377-58-2
|
C9H7BrN2O
|
|
3-[4-[2-(2,5-Dichloro-4-nitrophenyl)ethenyl]-1-piperazinyl]-1,2-benzisothiazole
|
160384-37-2
|
C19H16Cl2N4O2S
|
|
3-[4-[2-(2,5-Dichloro-4-nitrophenyl)ethyl]-1-piperazinyl]-1,2-benzisothiazole
|
160384-38-3
|
C19H18Cl2N4O2S
|
|
2-[5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-4-chloro-2-nitrophenyl]-propanedioic Acid 1,3-DiMethyl Ester
|
160384-39-4
|
C24H25ClN4O6S
|
|
5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-4-chloro-2-nitro-benzeneacetic Acid
|
160384-40-7
|
C21H21ClN4O4S
|
|
SP-8-PCPT-CGMPS SODIUM SALT
|
160385-87-5
|
C16H15ClN5O6PS2
|
|
6-Azabicyclo[3.2.0]hept-2-ene-2-carboxylicacid,7-oxo-,cis-(9CI)
|
160385-98-8
|
C7H7NO3
|
|
1-Propanone, 2-chloro-1-(3-methoxyphenyl)- (9CI)
|
160388-15-8
|
C10H11ClO2
|
|
1-Propanone, 2-chloro-1-(3-methylphenyl)- (9CI)
|
160388-16-9
|
C10H11ClO
|
|
N-(Phenylmethoxy)-1,5-pentanediamine
|
160388-21-6
|
C12H20N2O
|
|
4-(1H-PYRAZOL-1-YLMETHYL)BENZOIC ACID
|
160388-53-4
|
C11H10N2O2
|
|
4-(1H-1,2,4-TRIAZOL-1-YLMETHYL)BENZOIC ACID
|
160388-54-5
|
C10H9N3O2
|
|
[4-(1H-PYRAZOL-1-YLMETHYL)PHENYL]METHANOL
|
160388-55-6
|
C11H12N2O
|
|
[4-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]METHANOL
|
160388-56-7
|
C10H11N3O
|
|
N-BIOTINYL GLYCINE
|
160390-90-9
|
C12H19N3O4S
|
|
TYRPHOSTIN AG 1290
|
160391-70-8
|
C10H6N2O6
|
|
|
POLYGLYCERYL-4 CAPRATE
|
160391-93-5
|
|
|
AK 295
|
160399-35-9
|
C26H40N4O6
|
|
[TETRA(DIPHENOXYPHOSPHORYL)!TETRA-METHYLCALIX[4!RESORCINOLARENE, 98
|
160399-36-0
|
C128H104O32P8
|
|
1,3-Cyclohexadiene-1-carboxylicacid,6-amino-5-hydroxy-(9CI)
|
160399-68-8
|
C7H9NO3
|
|
Cyclohexanamine, 5-methyl-2-(1-methylethyl)-, [1S-(1alpha,2ba,5ba)]- (9CI)
|
160399-90-6
|
C10H21N
|
|
Cyclohexanamine, 2-methyl-5-(1-methylethyl)-, [1S-(1alpha,2ba,5ba)]- (9CI)
|
160399-91-7
|
C10H21N
|
|
Cyclohexanamine, 2-methyl-5-(1-methylethyl)-, [1R-(1alpha,2alpha,5alpha)]- (9CI)
|
160399-92-8
|
C10H21N
|
|
N-Boc-5-oxo-DL-proline
|
160401-16-1
|
C10H15NO5
|
|
|
env-Mlvi-4 fusion protein
|
160405-94-7
|
|
|
1H-Cyclopenta[b]quinoxaline,2-methyl-(9CI)
|
160409-72-3
|
C12H10N2
|
|
5-CHLORO-3-(3,4-DIMETHOXYPHENYL)ISOXAZOLE
|
160414-05-1
|
C11H10ClNO3
|
|
(2S)-(+)-5,5-DIMETHYL-2-MORPHOLINEACETIC ACID
|
160415-07-6
|
C8H16ClNO3
|
|
Carbamic acid, 1,3,4-thiadiazol-2-yl-, 1,1-dimethylethyl ester (9CI)
|
160416-00-2
|
C7H11N3O2S
|
|
Carbamic acid, 1H-1,2,4-triazol-3-yl-, 1,1-dimethylethyl ester (9CI)
|
160416-01-3
|
C7H12N4O2
|
|
tert-butyl N-(4,6-dimethoxy-2-pyrimidyl)carbamate
|
160416-02-4
|
C11H17N3O4
|
|
Carbamic acid, (1-ethyl-1H-pyrazol-5-yl)-, 1,1-dimethylethyl ester (9CI)
|
160416-03-5
|
C10H17N3O2
|
|
N-Allyl-6-chloro-4-pyrimidinamine
|
160416-47-7
|
C7H8ClN3
|
|
2H-Pyrrole,3,4-dihydro-5-(1-methylpropyl)-(9CI)
|
160423-54-1
|
C8H15N
|
|
1,1-DIPHENYL-TETRAHYDRO-PYRROLO[1,2-C]OXAZOL-3-ONE
|
160424-29-3
|
C18H17NO2
|
|
1H-Imidazole-5-carboxaldehyde, 1-(methoxymethyl)- (9CI)
|
160425-46-7
|
C6H8N2O2
|
|
1H-Imidazole,5-ethenyl-1-(methoxymethyl)-(9CI)
|
160425-47-8
|
C7H10N2O
|
|
2-(T-BUTYL DIMETHYLSILYL)-1-METHYL IMADAZOLE
|
160425-48-9
|
C10H20N2Si
|
|
3(2H)-Pyridazinone,6-ethyl-4-methyl-(9CI)
|
160427-26-9
|
C7H10N2O
|
|
3-CHLORO-TETRAHYDRO-PYRAN-4-ONE
|
160427-98-5
|
C5H7ClO2
|
|
2-Ethenyl-5-oxo-1-pyrrolidinecarboxylic Acid tert-Butyl Ester
|
160428-64-8
|
C11H17NO3
|
|
2-Pentenoic acid, 2-hydroxy-4-oxo- (9CI)
|
160428-94-4
|
C5H6O4
|
|
Acetamiprid
|
160430-64-8
|
C10H11ClN4
|
|
2 6-DICHLORO-3-HYDROXY-4-METHOXYBENZALD&
|
160431-96-9
|
C8H6Cl2O3
|
|
4-DesMethyl Istradefylline
|
160434-48-0
|
C19H22N4O4
|
|
3-BROMO-4-FLUOROCINNAMIC ACID
|
160434-49-1
|
C9H6BrFO2
|
|
3',5,5',7-Tetrahydroxyflavane
|
160436-10-2
|
C15H12O6
|
|
ETHYL 3-AMINO-4-(TRIFLUOROMETHYL)-6-PHENYLFURO[2,3-B]PYRIDINE-2-CARBOXYLATE
|
160436-48-6
|
C17H13F3N2O3
|
|
ETHYL 3-AMINO-4-(TRIFLUOROMETHYL)-6-P-TOLYLFURO[2,3-B]PYRIDINE-2-CARBOXYLATE
|
160436-49-7
|
C18H15F3N2O3
|
|
ETHYL 3-AMINO-4-(TRIFLUOROMETHYL)-6-(4-METHOXYPHENYL)FURO[2,3-B]PYRIDINE-2-CARBOXYLATE
|
160436-50-0
|
C18H15F3N2O4
|
|
ETHYL 3-AMINO-6-(4-CHLOROPHENYL)-4-(TRIFLUOROMETHYL)FURO[2,3-B]PYRIDINE-2-CARBOXYLATE
|
160436-51-1
|
C17H12ClF3N2O3
|
|
|
Alcohols, C12-14-secondary, .beta.-bis(hydroxyethyl)amino, ethoxylated
|
160441-82-7
|
|
|
2-(6,7-diMethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethanaMine
|
160446-15-1
|
C13H20N2O2
|
|
METHYL 4-(1H-IMIDAZOL-1-YLMETHYL)BENZOATE
|
160446-18-4
|
C12H12N2O2
|
|
METHYL 4-(METHANESULFONYLMETHYL)BENZOATE
|
160446-22-0
|
C10H12O4S
|
|
3-(N-1-TRITYL-IMIDAZOL-4-YL)PROPIONIC ACID
|
160446-35-5
|
C25H22N2O2
|
|
N-BOC-3-AMINO-4-CHLOROBENZOIC ACID
|
160450-12-4
|
C12H14ClNO4
|
|
1H-Isoindol-1-one, 2,3-dihydro-6-phenyl-
|
160450-16-8
|
C14H11NO
|
|
2,4-bis(oxiran-2-ylmethyl)-5-propan-2-yl-1,2,4-triazol-3-one
|
160455-70-9
|
C11H17N3O3
|
|
6-ISOCYANATOQUINOLINE
|
160455-77-6
|
C10H6N2O
|
|
2-Pentenal, 3-methyl-4-oxo-, (E)- (9CI)
|
160456-54-2
|
C6H8O2
|